InvestorsHub Logo
Followers 92
Posts 17169
Boards Moderated 0
Alias Born 09/06/2006

Re: extrooper post# 403808

Thursday, 09/23/2021 12:17:51 PM

Thursday, September 23, 2021 12:17:51 PM

Post# of 688196

Expect a quick approval in the UK , based on dcvax being one of the first to get approval for use in their early use program EAMS in 2014


There and still not been a case where the UK approval for a novel oncology came the EU (or FDA in case of ORBIS) approval. All they have done is piggyback on those two agencies

The first drug in the UK super duper innovative passport program was approved by the FDA a month ago. Still have not seen a CHMP recommendation. NICE has it on the calendar for next summer.

A few others in that program have been announced. We shall see, but I see little reason to believe that the UK will go from one of the slowest to one of the fastest.

They could have sped up the NICE process before Brexit, but they did not.

BTW, DCVax-L was never was approved under EAMS. They got the easy part, but still needed clinical evidence that it really works.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News